Related Experiment Video
Updated: Jan 21, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Complete Versus Culprit only Revascularisation in Patients with Cardiogenic Shock Complicating Acute Myocardial
Krishnaraj S Rathod1, Sudheer Koganti1, Ajay K Jain1
1Barts Health NHS Trust, London, United Kingdom of Great Britain and Northern Ireland.
Insights
Complete revascularisation in ST-segment myocardial infarction (STEMI) patients with cardiogenic shock (CS) and multi-vessel disease (MVD) is associated with reduced mortality. This approach appears more beneficial than treating only the culprit vessel.
Area of Science:
- Cardiology
- Interventional Cardiology
- Clinical Research
Background:
- Cardiogenic shock (CS) in ST-segment myocardial infarction (STEMI) patients has high mortality rates.
- Multi-vessel disease (MVD) is common in these patients, but optimal treatment remains unclear.
Purpose of the Study:
- To assess management trends for CS patients with MVD.
- To compare outcomes of complete revascularisation versus culprit-only revascularisation in STEMI patients with CS and MVD.
Main Methods:
- Observational cohort study of 1058 STEMI patients with CS and MVD from 2005-2015.
- Prospective data collection from British Cardiac Intervention Society (BCIS) PCI dataset.
- Follow-up for a median of 4.1 years, analyzing all-cause mortality.
Main Results:
- Complete revascularisation was performed in 47.0% of patients, with stable rates over time.
- Crude in-hospital MACE rates were similar, but Kaplan-Meier analysis showed no significant difference in mortality.
- Multivariate Cox analysis and propensity matching revealed complete revascularisation was associated with reduced mortality (HR 0.69 and 0.81, respectively).
Conclusions:
- Complete revascularisation in STEMI patients with CS and MVD is associated with improved outcomes compared to culprit-vessel-only intervention.
- Findings support ongoing clinical trials and provide evidence for complete revascularisation in STEMI.
- This strategy may improve survival rates in high-risk cardiac patients.
Background:
Despite advances in technology, patients with Cardiogenic Shock (CS) presenting with ST-segment myocardial infarction (STEMI) still have a poor prognosis with high mortality rates. A large proportion of these patients have multi-vessel coronary artery disease, the treatment of which is still unclear. We aimed to assess the trends in management of CS patients with multi-vessel disease (MVD), particularly looking at the incidence and outcomes of complete revascularisation compared to culprit vessel only.
Methods And Results:
We undertook an observational cohort study of 21,210 STEMI patients treated between 2005 and 2015 at the 8 Heart Attack Centres in London, UK. Patients' details were recorded prospectively into local databases using the British Cardiac Intervention Society (BCIS) PCI dataset. 1058 patients presented with CS and MVD. Primary outcome was all-cause mortality. Patients were followed-up for a median of 4.1 years (IQR range: 2.2-5.8 years). 497 (47.0%) patients underwent complete revascularisation during primary PCI for CS with stable rates seen over time. These patients were more likely to be male, hypertensive and more likely to have poor LV function compared to the culprit vessel intervention group. Although crude, in hospital major adverse cardiac events (MACE) rates were similar (40.8% vs. 36.0%, p = 0.558) between the two groups. Kaplan-Meier analysis demonstrated no significant differences in mortality rates between the two groups (53.8% complete revascularisation vs. 46.8% culprit vessel intervention, p = 0.252) during the follow-up period. After multivariate cox analysis (HR 0.69 95% CI (0.44-0.98)) and the use of propensity matching (HR: 0.81 95% CI: 0.62-0.97) complete revascularisation was associated with reduced mortality. A number of co-variates were included in the model, including age, gender, diabetes, hypertension, hypercholesterolaemia, previous PCI, previous MI, chronic renal failure, Anterior infarct, number of treated vessels, pre-procedure TIMI flow, procedural success and GP IIb/IIIA use.
Conclusion:
In a contemporary observational series of CS patients with MVD, complete revascularisation appears to be associated with better outcomes compared to culprit vessel only intervention. This supports on-going clinical trials in this area and provides further evidence of the association of complete revascularisation in STEMI with good outcomes.
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Acid Attack on Concrete
The rate at which hydrogen...
Sulfate Attack on Concrete
Sulfates from sources like soil, groundwater, or industrial effluents...
Shock Waves
When the source's speed approaches the speed of sound, constructive interference between successive wavefronts emitted by the source occurs immediately behind it. Initially, scientists believed that this constructive interference would result in such high...
Types of Reports II: Incident or Occurrence Report
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
Hemodialysis II: Procedure and Complications

